Dr. Linda Oyama is a Lecturer in Microbiomics at Queen's University Belfast, United Kingdom She has a substantial track record in publishing within the field of microbiology in relation to tackling key societal challenges including infectious diseases in the clinical and agricultural sectors. She is currently studying livestock gastrointestinal tract microbiomes, with a particular focus on understanding the evolution and dispersal of antimicrobial resistance (AMR). Specifically, she has expertise in meta-‘omic approaches to study gut microbiomes for antimicrobial resistance (AMR) surveillance and the discovery of novel antimicrobials within livestock microbiomes to combat the challenges of AMR. In the last 6 years, Dr. Oyama's research has resulted in excellence in the design, implementation and analyses of multi-‘omic datasets, including metagenomics and metatranscriptomics, pioneering the combination of in-silico and wet-lab molecular microbiology approaches to escalate drug discovery research addressing the imminent AMR problem facing veterinary and human medicine.